We are de-risking biomedical innovation, turning biomedical knowledge into social and economic value.
More than three decades later, we remain committed in pursuit of pharmaceutical innovation, providing high quality products and striving to deliver superior business results.
The patient is at the heart of what we do, making decisions regarding biometric innovation is usually a complicated and chaotic procedure as it consists of various product options, various facets to ascertain these on, and multiple evaluations at all levels.
Discover our therapeutic areas, where we continuously invest to innovate and deliver therapeutic solutions for patient’s benefit.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
11
Jun 2026
Researchers at the University of California San Diego have completed a massive genetic study that identifies key biological drivers of cocaine addiction, uncovering a potential new target for treatment that resides in the liver rather than the brain.
11
Jun 2026
Blood pressure management after thrombectomy for acute ischemic stroke may require a change in approach.
11
Jun 2026
Announcing a new article publication for Zoonoses journal. Bacterial zoonoses such as brucellosis, salmonellosis, leptospirosis, anthrax, campylobacteriosis, and listeriosis remain major global health threats with substantial economic and social effects.
11
Jun 2026
Keck Medicine of USC hospitals and USC Student Health, part of Keck Medicine, received the LGBTQ+ Healthcare Equality Leader designation in the Human Rights Campaign Foundation's 2026 Healthcare Equality Index (HEI).